NEW YORK STOCK EXCHANGE, INC. · AORT
-2.22% · -$0.5300 · Vol 1.9M
Market closed · last close 4:00 PM ET · price as of 19:00:00 ET
Artivion Inc

Artivion Inc

Health Care
$23.35
Card
Relationship Map

Follow $AORT

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $AORT by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
AORT
Artivion Inc
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

70/ 100
Veridion Score
Upper range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 5 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is AORT moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading AORT catalysts
About Artivion Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
1993
Employees
2K
Country
US

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$23.80
Day high
$24.25
Day low
$23.30
Previous close
$23.88
52W high
$47.63
-50.98% from high
52W low
$20.10
12% of range
Market cap
$1.1B
P/E
116.55×
EPS
$-0.0900
Beta
0.07
Shares out
48.8M
Volume
1.9M
2.66× rel vol
Avg volume
718.9K
VWAP
$23.46
Price history computed in-house
1W
-6.49%
1M
-16.84%
3M
+12.91%
1Y
-42.42%
YTD
-48.81%
SMA 50 $26.25 · below
SMA 200 $32.79 · below
52W position 12%

AORT overview

Loading financial statements
Loading AORT Form 4 filings
Public disclosures

Congress activity in AORT

Federal contracts

AORT contract awards, year to date.

Public federal awards linked to this ticker.

$245.6K
Refresh interval: 12hSource: Federal contract awards
Department of Veterans Affairs
$58.3K
PROSTHETICS

PROSTHETICS: PRE-BUY PULMONARY VALVES SURGICAL IMPLANTS

Jun 29, 2026
Department of Veterans Affairs
$58.3K
PROSTHETICS - PULMONARY VALVES

PROSTHETICS - PULMONARY VALVES

May 26, 2026
Department of Veterans Affairs
$50.3K
PROSTHETICS

PROSTHETICS: PULMONARY VALVES SURGICAL IMPLANTS

Apr 20, 2026
Department of Veterans Affairs
$23.1K
IMPLANT

IMPLANT

Aug 26, 2026
Department of Veterans Affairs
$19.9K
PROSTHETIC ORDER

PROSTHETIC ORDER

Apr 8, 2026
Lobbying spend

AORT lobbying filings, year to date.

Registered lobbying filings matched to Artivion Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for AORT in this window.
Loading news for AORT
Analyst ratings
Sovereign unlock shows live analyst consensus for AORT.
Options
Sovereign unlock shows live options positioning for AORT.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.